• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与钼辅因子缺乏相关的球形晶状体

Spherophakia associated with molybdenum cofactor deficiency.

作者信息

Parini R, Briscioli V, Caruso U, Dorche C, Fortuna R, Minniti G, Selicorni A, Vismara E, Mancini G

机构信息

Istituto di Pediatria, Ospedale Istituti Clinici di Perfezionamento, Milano, Italy.

出版信息

Am J Med Genet. 1997 Dec 19;73(3):272-5. doi: 10.1002/(sici)1096-8628(19971219)73:3<272::aid-ajmg8>3.0.co;2-u.

DOI:10.1002/(sici)1096-8628(19971219)73:3<272::aid-ajmg8>3.0.co;2-u
PMID:9415683
Abstract

Molybdenum cofactor deficiency is an autosomal recessive disorder characterized by lack of activity of the enzymes sulfite oxidase, aldehyde oxidase, and xanthine dehydrogenase or oxidase. The clinical manifestations are indistinguishable from those of isolated sulfite oxidase deficiency: craniofacial alterations, intractable neonatal convulsions, very severe mental retardation, lens dislocation, and death in the first decade of life. Lens dislocation is found in nearly all patients after neonatal age. In the present case it developed late (at the age of 8 years) and was preceded by bilateral spherophakia. We hypothesize that an abnormal relaxation of the zonular fibers is the cause of spherophakia in this disease; this causes lens dislocation eventually, after days, months, or years.

摘要

钼辅因子缺乏症是一种常染色体隐性疾病,其特征是亚硫酸盐氧化酶、醛氧化酶以及黄嘌呤脱氢酶或氧化酶缺乏活性。临床表现与孤立性亚硫酸盐氧化酶缺乏症无法区分:颅面畸形、难治性新生儿惊厥、极重度智力发育迟缓、晶状体脱位以及在生命的第一个十年内死亡。几乎所有新生儿期后的患者都会出现晶状体脱位。在本病例中,晶状体脱位出现较晚(8岁时),且之前有双侧球形晶状体。我们推测,在这种疾病中,悬韧带纤维异常松弛是球形晶状体的病因;这最终会在数天、数月或数年之后导致晶状体脱位。

相似文献

1
Spherophakia associated with molybdenum cofactor deficiency.与钼辅因子缺乏相关的球形晶状体
Am J Med Genet. 1997 Dec 19;73(3):272-5. doi: 10.1002/(sici)1096-8628(19971219)73:3<272::aid-ajmg8>3.0.co;2-u.
2
[Xanthine oxidase deficiency (hereditary xanthinuria), molybdenum cofactor deficiency].[黄嘌呤氧化酶缺乏症(遗传性黄嘌呤尿症),钼辅因子缺乏症]
Nihon Rinsho. 1996 Dec;54(12):3333-6.
3
[Double deficiency of sulfite and xanthine oxidase causing encephalopathy and due to a hereditary anomaly in the metabolism of molybdenum].[亚硫酸盐和黄嘌呤氧化酶双重缺乏导致脑病,病因是钼代谢的遗传性异常]
Ann Med Interne (Paris). 1982;133(8):594-6.
4
Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor.钼代谢的先天性缺陷:一名缺乏钼辅因子患者中,亚硫酸盐氧化酶和黄嘌呤脱氢酶的联合缺乏。
Proc Natl Acad Sci U S A. 1980 Jun;77(6):3715-9. doi: 10.1073/pnas.77.6.3715.
5
Absence of hepatic molybdenum cofactor. An inborn error of metabolism associated with lens dislocation.
Ophthalmic Paediatr Genet. 1985 Apr;5(3):191-5. doi: 10.3109/13816818509006133.
6
Molybdenum co-factor deficiency: an easily missed inborn error of metabolism.钼辅因子缺乏症:一种易被漏诊的先天性代谢紊乱疾病。
Dev Med Child Neurol. 1988 Aug;30(4):531-5. doi: 10.1111/j.1469-8749.1988.tb04781.x.
7
Ophthalmic abnormalities in molybdenum cofactor deficiency and isolated sulfite oxidase deficiency.
J Pediatr Ophthalmol Strabismus. 1995 Sep-Oct;32(5):334-7. doi: 10.3928/0191-3913-19950901-16.
8
[Hereditary xanthinuria and molybdenum cofactor deficiency].[遗传性黄嘌呤尿症和钼辅因子缺乏症]
Nihon Rinsho. 2003 Jan;61 Suppl 1:377-82.
9
Anatomo-pathological findings in a case of combined deficiency of sulphite oxidase and xanthine oxidase with a defect of molybdenum cofactor.一例亚硫酸盐氧化酶和黄嘌呤氧化酶联合缺乏伴钼辅因子缺陷病例的解剖病理学发现
Virchows Arch A Pathol Anat Histopathol. 1985;405(3):379-86. doi: 10.1007/BF00710072.
10
Absence of hepatic molybdenum cofactor: an inborn error of metabolism leading to a combined deficiency of sulphite oxidase and xanthine dehydrogenase.肝钼辅因子缺乏:一种导致亚硫酸盐氧化酶和黄嘌呤脱氢酶联合缺乏的先天性代谢缺陷。
J Inherit Metab Dis. 1983;6 Suppl 1:78-83. doi: 10.1007/BF01811328.

引用本文的文献

1
Early Neonatal Fosdenopterin Treatment for Molybdenum Cofactor Deficiency Type A: New Insights into Its Natural History and Potential Role for Fetal Therapy.早期新生儿用福斯登蝶呤治疗A型钼辅因子缺乏症:对其自然病史及胎儿治疗潜在作用的新认识
J Clin Med. 2025 May 20;14(10):3561. doi: 10.3390/jcm14103561.
2
Ocular characteristics of a 6-year-Old boy with molybdenum cofactor deficiency type B.一名患有B型钼辅因子缺乏症的6岁男孩的眼部特征。
Am J Ophthalmol Case Rep. 2022 May 14;27:101586. doi: 10.1016/j.ajoc.2022.101586. eCollection 2022 Sep.
3
Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature.
钼辅因子缺乏症的轻度表型:一位新患者及文献复习。
Mol Genet Genomic Med. 2019 Jun;7(6):e657. doi: 10.1002/mgg3.657. Epub 2019 Mar 21.
4
Molybdenum cofactor and isolated sulphite oxidase deficiencies: Clinical and molecular spectrum among Egyptian patients.钼辅因子和孤立性亚硫酸盐氧化酶缺乏症:埃及患者的临床和分子谱系
Eur J Paediatr Neurol. 2016 Sep;20(5):714-22. doi: 10.1016/j.ejpn.2016.05.011. Epub 2016 May 30.